Overview
- Editors:
-
-
Gary W. Elmer
-
Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, USA
-
Lynne V. McFarland
-
Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, USA
Biocodex Inc., Seattle, USA
-
Christina M. Surawicz
-
Department of Medicine, Harborview Medical Center, University of Washington, Seattle, USA
Access this book
Other ways to access
Table of contents (13 chapters)
-
-
-
-
- Steven W. Martin, Anne C. Heatherington, Gary W. Elmer
Pages 47-84
-
- Kerstin Orrhage, Carl Erik Nord
Pages 85-120
-
- Philippe Marteau, Christophe Cellier
Pages 121-144
-
-
-
-
- S. Salminen, E. Isolauri, E. Salminen
Pages 207-220
-
-
- Gregor Reid, Vladimir Smeianov, Andrew W. Bruce
Pages 245-261
-
- Christina M. Surawicz, Lynne V. McFarland
Pages 263-268
-
- Gerard Corthier, Pierre Renault
Pages 269-304
-
Back Matter
Pages 305-316
About this book
Authoritative investigators active in the discovery, development, and application of biological anti-infective agents concisely review their use and potential in preventing and treating human disease. Focusing on biotherapeutic entities that have been tested in controlled studies, the prominent experts illuminate the scientific underpinnings of their therapeutic power, assess their possible risks in the treatment of infectious diseases, and outline the research needed to better define their effectiveness. In addition, they also consider how biotherapeutic agents may be genetically engineered for maximum intestinal and vaginal production of bioactive substances in vivo. Biotherapeutic Agents and Infectious Diseases brings together all the evidence needed to understand and capitalize on the considerable promise of this significant new class of biotherapeutic entities.
Reviews
"This book does a good job explaining what a biotherapeutic agent is and what role it may play in the areas of microbiology, infectious disease resistance, and treatment options. . .It is written in a manner that those in a wide variety of disciplines would have no difficulty understanding. . .[the book is] interesting and challenging to some of our goals in the area of chemotherapy-resistant pathogens of the future."-Doody's Health Sciences Book Review Journal
